Cart
sales@molnova.com
Anecortave Acetate
CAS No. 7753-60-8
Anecortave Acetate ( Anecortave Acetate ; Anecortave; Al 3789; NSC 15475; NSC 24345; Retaane )
Catalog No. M27409 CAS No. 7753-60-8
Anecortave Acetate, an angiostatic steroid, is used for proteomics research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | Get Quote |
|
| 10MG | 63 | Get Quote |
|
| 25MG | 103 | Get Quote |
|
| 50MG | 150 | Get Quote |
|
| 100MG | 223 | Get Quote |
|
| 500MG | 482 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAnecortave Acetate
-
NoteResearch use only, not for human use.
-
Brief DescriptionAnecortave Acetate, an angiostatic steroid, is used for proteomics research.
-
DescriptionAnecortave Acetate, an angiostatic steroid, is used for proteomics research.
-
SynonymsAnecortave Acetate ; Anecortave; Al 3789; NSC 15475; NSC 24345; Retaane
-
PathwayOthers
-
TargetOther Targets
-
RecptorLigand for E3 Ligase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number7753-60-8
-
Formula Weight386.5
-
Molecular FormulaC23H30O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)C3=CC[C@]12C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.George W. Muller, et al. Substituted 2-(2,6 dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing TNFα levels. Patent US5874448A.
molnova catalog
related products
-
Schisantherin C
Schisantherin A, B, C, and D show good effect in lowering the serum glutamic-pyruvic transaminase level of the patients suffering from chronic virus hepatitis.
-
Sodium thioglycolate
Sodium thioglycolate is a disulfide reducing agent.
-
ML-180
ML-180 is a potent orphan nuclear receptor liver receptor homolog 1 (LRH-1; NR5A2) inverse agonist (IC50 of 3.7 μM) .ML-180 (0.5-5 μM; 24 hours) shows a significant inhibition of cyclin-D1 and cyclin-E1 expression in hepatic cells, but has little effect on repression in SK-OV-3 cells[2]. ML-180 (5 μM; 24 hours) leads to a rapid decrease of LRH-1 expression and efficiently represses endogenous LRH-1 signaling.
